Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ohio study aims to beat lung cancer with tailored treatments

NCT ID NCT03199651

Recruiting now Disease control Sponsor: Ohio State University Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Feb 21, 2026 · Last updated May 10, 2026 · Updated 13 times

Summary

This study is testing whether a personalized care plan, which includes advanced genomic testing and immunotherapy, can help people with stage IV non-small cell lung cancer live longer and feel better. About 3,500 current or former smokers with this cancer will be followed to see if tailored treatments improve survival and quality of life compared to standard care. The goal is to find the most effective and less toxic therapies for each patient.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CURRENT SMOKER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ohio State University Comprehensive Cancer Center

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

CIGARETTE SMOKER CIGARETTE SMOKER CURRENT SMOKER LUNG ADENOCARCINOMA SQUAMOUS CELL LUNG CARCINOMA STAGE IV NON-SMALL CELL LUNG CANCER STAGE IV NON-SMALL CELL LUNG CANCER